Form 4 Filing for SOPHiA GENETICS SA

Daan Van Well, Chief Legal Officer of SOPHiA GENETICS SA, reported the sale of 2,400 ordinary shares on April 10, 2026. The shares were sold at a weighted average price of $4.6672, with individual transactions ranging from $4.61 to $4.77. These sales were executed under a pre-established Rule 10b5-1(c) trading plan to cover tax withholding obligations related to vested restricted stock units. Following these transactions, Van Well owns 346,420 shares. The filing also notes that the exact number of shares sold at each price within the reported range will be provided upon request.